GlassScriptPhysician profile
Kathryn M Ray
NPI 1275620700
$3,502.54
in general payments reported to CMS, 2019-2025
33 companies · $631 in 2025
The $631 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $111 · 2021: $26.79 · 2022: $302 · 2023: $929 · 2024: $835 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,220 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,220.29 |
| Education | $175.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $496.28 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $473.61 | 2022-2025 | |
| Abbvie INC. | $311.59 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $243.69 | 2024 | Spravato |
| Hologic Sales and Service, LLC | $241.96 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $225.30 | 2023-2024 | Myfembree |
| Organon LLC | $171.91 | 2022-2025 | Nexplanon, Nuvaring |
| Coopersurgical, INC. | $167.52 | 2019-2024 | Paragard T 380a, Insorb, Paragard T 380a |
| Exeltis, USA INC. | $144.71 | 2019-2025 | Slynd |
| Pfizer INC. | $128.18 | 2023-2025 | |
| Duchesnay USA Incorporated | $86.01 | 2019 | |
| Avion Pharmaceuticals | $72.67 | 2019-2023 | Balcoltra |
| Millicent US INC | $69.96 | 2025 | Intrarosa, Femlyv, Femring |
| Bard Access Systems, INC. | $68.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.48 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $65.02 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Baxter Healthcare | $56.77 | 2025 | Tisseel |
| Merck Sharp & Dohme LLC | $45.16 | 2020-2024 | Gardasil 9, Gardasil |
| Lupin INC. | $43.97 | 2019-2020 | |
| Therapeuticsmd, INC. | $43.87 | 2019-2020 | |
| Dysis Medical, INC. | $42.14 | 2019-2022 | |
| Allergan, INC. | $38.12 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.65 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $26.19 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.86 | 2019 | |
| Exact Sciences Corporation | $21.73 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $20.18 | 2025 | Zurzuvae |
| Covidien LP | $16.92 | 2019 | |
| Channel Medsystems, INC. | $16.65 | 2023 | |
| Pharmacosmos Therapeutics INC. | $12.96 | 2022 | |
| Acessa Health INC. | $11.89 | 2019 | |
| Monaghan Medical Corporation | $10.03 | 2023 | Aerochamber |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.